Announcements Trials
Browse Landscape

Phase

Phase 1 8Phase 1/2 6Phase 2 5Phase 2/3 1

Status

Completed 3Not yet recruiting 2Active not recruiting 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 3Head & Neck 1Dermatologic 1

Conditions

Melanoma 10Colorectal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Neoplasms 4Neoplasm Metastasis 3Lung Neoplasms 2Glioma 2Uveal Melanoma 1Thyroid Neoplasms 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neurofibromatosis 1 1Neurofibroma, Plexiform 1Neuroblastoma 1Multiple Myeloma 1Leukemia, Myelomonocytic, Juvenile 1Leukemia 1Histiocytosis, Langerhans-Cell 1Hematologic Neoplasms 1Cholangiocarcinoma 1Bile Duct Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Cetuximab 44Oxaliplatin 39Irinotecan 38Fluorouracil 36Capecitabine 36pembrolizumab 35Leucovorin 35Bevacizumab 35Nivolumab 21Gemcitabine 17regorafenib 13Panitumumab 12IFL protocol 12Folfox protocol 12Cyclophosphamide 12Pemetrexed 11Cisplatin 11tislelizumab 9Paclitaxel 9HMPL-013 9Carboplatin 9130-nm albumin-bound paclitaxel 8durvalumab 7Specimen Handling 7Docetaxel 7trametinib 6Trifluridine 6Ipilimumab 6Drug Therapy 6trifluridine tipiracil drug combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 1/2 × Colorectal Neoplasms × trametinib × Clear all
NCT05358249 2026-04-14

KontRASt-03

Novartis

Phase 1/2 Active not recruiting
74 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT07468071 2026-04-02

KontRASt-R

Novartis

Phase 1/2 Not yet recruiting
40 enrolled
GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Colorectal Neoplasms

NCT03377361 2025-12-03

CheckMate 9N9

Bristol-Myers Squibb

Phase 1/2 Completed
325 enrolled 31 charts
Gastrointestinal

Colorectal Neoplasms

NCT02230553 2025-07-08

M14LTK

The Netherlands Cancer Institute

Phase 1/2 Completed
35 enrolled
Gastrointestinal

Colorectal Neoplasms

NCT05275374 2025-04-10

ENHANCE

Xynomic Pharmaceuticals, Inc.

Phase 1/2 Not yet recruiting
221 enrolled
DermatologicGastrointestinalHead & NeckThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms, Thyroid Neoplasms, Colorectal Neoplasms

NCT01750918 2021-10-29

BRAF/MEK/EGFR Inhibitor Combination Study in Colorectal Cancer (CRC)

Novartis

Phase 1/2 Completed
166 enrolled 46 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡